Products for Research Use Only
RegisterLogin

Trametinib (GSK1120212)

CAT: 1568-C08769-5mgSize: 5 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:1568-C08769-5mgSize:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
871700-17-3
Synonyms
JTP-74057
Target
MEK
Applications
Protein Tyrosine Kinase
Smiles
CC1=C2C (=C (N (C1=O) C) NC3=C (C=C (C=C3) I) F) C (=O) N (C (=O) N2C4=CC=CC (=C4) NC (=O) C) C5CC5
Molecular Formula
C26H23FIN5O4
Additionnal Information
Trametinib (GSK1120212, JTP-74057) is a highly specific and potent MEK1/2 inhibitor with IC50 of 0.92 nM/1.8 nM in cell-free assays, no inhibition of the kinase activities of c-Raf, B-Raf, ERK1/2. Trametinib activates autophagy and induces apoptosis.
Storage Conditions
2 years -80 in solvent

Chemical Information

Trametinib

Trametinib is a pyridopyrimidine that is used (as its dimethyl sulfoxide addition compound) for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations, and who have not received prior BRAF inhibitor treatment. It has a role as an anticoronaviral agent, a geroprotector, an antineoplastic agent and an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor. It is a member of acetamides, an aromatic amine, a ring assembly, an organoiodine compound, an organofluorine compound, a pyridopyrimidine and a member of cyclopropanes.

CAS Number871700-17-3
PubChem CID11707110
IUPAC NameN-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide
Molecular FormulaC26H23FIN5O4
Molecular Weight615.4
XLogP3.4
Topological Polar Surface Area102
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count5
Heavy Atom Count37
Formal Charge0
Complexity1090
SMILES
CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5
InChI
InChI=1S/C26H23FIN5O4/c1-13-22-21(23(31(3)24(13)35)30-20-10-7-15(28)11-19(20)27)25(36)33(17-8-9-17)26(37)32(22)18-6-4-5-16(12-18)29-14(2)34/h4-7,10-12,17,30H,8-9H2,1-3H3,(H,29,34)
InChIKey
LIRYPHYGHXZJBZ-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of Trametinib
CAS: 871700-17-3
CID: 11707110
Formula: C26H23FIN5O4
MW: 615.4
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight615.4
XLogP33.4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count5
Exact Mass615.07788
Monoisotopic Mass615.07788
Topological Polar Surface Area102 Ų
Heavy Atom Count37
Formal Charge0
Complexity1090
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
C10165-5mgTrametinib DMSO solvate
C10165-25mgTrametinib DMSO solvate
C10165-100mgTrametinib DMSO solvate
C10165-1gTrametinib DMSO solvate
C10165-01Trametinib DMSO solvate

Alternative Products

CatalogName
S2673-10mM/1mLTrametinib (GSK1120212)
MBS384815-01GSK1120212 (JTP-74057, Trametinib)
A11029-500GSK1120212 (JTP-74057, Trametinib) 500mg
A11029-200GSK1120212 (JTP-74057, Trametinib) 200mg
GW7563-5mgGSK1120212
A11029-50GSK1120212 50mg
A11029-10GSK1120212 10mg
A11029-100GSK1120212 100mg
A11029-5GSK1120212 5mg
T2125-01Trametinib

Popular Products